5-Layer StackThe Clav Protocol
−28.7%Retatrutide Phase 2
11 TotalStack Compounds
>98%HPLC Purity
$200+Free Shipping
Full catalog
Skinnymaxxing reference catalog · 40 compounds

Skinnymaxxing

Skinnymaxxing is the combined fat-loss shelf: every GLP-class incretin receptor agonist alongside the metabolic-mechanism compounds that act through separate pathways. The GLP entries are grouped by receptor tier — mono-agonist (GLP-1), dual (GLP-1/GIP), and triple (GLP-1/GIP/glucagon). The metabolic entries are grouped by mechanism of action: mitochondrial uncouplers, AMPK activators, lipolysis modulators, amylin analogues, and myostatin inhibitors. Every entry is presented for educational reading of the published pharmacology and supplied for laboratory research use only, priced per vial with a lot-matched Certificate of Analysis confirming \u226598% HPLC purity. Several molecules below are investigational or prescription-only drugs; nothing here is medical advice or a recommendation for personal use.

Triple Agonist

GLP-1 · GIP · Glucagon

Retatrutide (investigational)

Dual Agonist

GLP-1 · GIP

Tirzepatide

Mono Agonist

GLP-1

Semaglutide

Mechanism Comparison

ClassPathwayKey ExamplesHalf-LifeProducts
UCPMitochondrial Uncoupler
Dissipates proton gradient → heat, raising basal metabolic rateBAM-15, 2,4-DNP analogs4–8 hours2
AMPKAMPK Activator
Mimics cellular low-energy state → fatty acid oxidation5-Amino-1MQ (NNMT inhibitor)12–16 hours3
LIPLipolysis / β-Oxidation
HSL activation, fat mobilization without affecting IGF-1AOD-9604, Adipotide30 min – 2 hours5
AMYAmylin / Satiety
Amylin-receptor signaling; gastric-emptying and satiety pathways in preclinical modelsCagrilintide, Amycretin7+ days (long-acting)0
MYOMyostatin / Growth-Axis
Myostatin-pathway inhibition; studied for lean-mass preservation in preclinical modelsACE-031, Follistatin-344varies0

Other Metabolic Compounds

Metabolic modulators outside the main mechanism classes.